Mupirocin/Target ointment

Mupirocin/Target is a topical antibiotic ointment used for skin infections, containing 2% mupirocin. This specific product is manufactured and marketed by Target Pharma, a pharmaceutical company based in Greece. The branding and Greek text ('Μουπιροσίνη', '15 g αλοιφή') indicate it is a product primarily intended for the Greek domestic pharmaceutical market.

Target Pharma was founded in Greece and remains an independent Greek pharmaceutical entity specialized in the retail and hospital sector. While mupirocin was originally developed by Beecham (now GlaxoSmithKline), this specific generic formulation is owned and produced by the Greek company Target Pharma.